Cabaletta Bio Files 8-K Report
Ticker: CABA · Form: 8-K · Filed: Oct 29, 2025 · CIK: 1759138
Sentiment: neutral
Topics: corporate-disclosure, 8-K
TL;DR
Cabaletta Bio filed an 8-K on 10/29/25, updating its corporate information.
AI Summary
On October 29, 2025, Cabaletta Bio, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 2929 Arch Street, Suite 600, Philadelphia, PA 19104. The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing serves as an official notification to the SEC and the public regarding the company's operational and reporting status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Cabaletta Bio, Inc. (company) — Registrant
- October 29, 2025 (date) — Date of earliest event reported
- 2929 Arch Street Suite 600 (location) — Principal Executive Offices
- Philadelphia, Pennsylvania (location) — City and State of Principal Executive Offices
- 19104 (location) — ZIP Code of Principal Executive Offices
- (267) 759-3100 (phone_number) — Registrant's Telephone Number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is October 29, 2025.
What is the full legal name of the company filing this report?
The full legal name of the registrant is Cabaletta Bio, Inc.
Where are Cabaletta Bio, Inc.'s principal executive offices located?
The principal executive offices are located at 2929 Arch Street, Suite 600, Philadelphia, Pennsylvania, 19104.
Under which sections of the Securities Exchange Act of 1934 is this 8-K report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the company's telephone number, including area code?
The company's telephone number, including area code, is (267) 759-3100.
Filing Stats: 442 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-10-29 07:01:44
Key Financial Figures
- $0.00001 — ch registered Common Stock, par value $0.00001 per share CABA The Nasdaq Global Se
Filing Documents
- caba-20251029.htm (8-K) — 47KB
- caba-ex99_1.htm (EX-99.1) — 83KB
- caba-ex99_1s1.jpg (GRAPHIC) — 189KB
- caba-ex99_1s2.jpg (GRAPHIC) — 1029KB
- caba-ex99_1s3.jpg (GRAPHIC) — 176KB
- caba-ex99_1s4.jpg (GRAPHIC) — 587KB
- caba-ex99_1s5.jpg (GRAPHIC) — 481KB
- caba-ex99_1s6.jpg (GRAPHIC) — 421KB
- caba-ex99_1s7.jpg (GRAPHIC) — 427KB
- caba-ex99_1s8.jpg (GRAPHIC) — 145KB
- caba-ex99_1s9.jpg (GRAPHIC) — 439KB
- caba-ex99_1s10.jpg (GRAPHIC) — 471KB
- caba-ex99_1s11.jpg (GRAPHIC) — 349KB
- caba-ex99_1s12.jpg (GRAPHIC) — 509KB
- caba-ex99_1s13.jpg (GRAPHIC) — 494KB
- caba-ex99_1s14.jpg (GRAPHIC) — 139KB
- caba-ex99_1s15.jpg (GRAPHIC) — 495KB
- caba-ex99_1s16.jpg (GRAPHIC) — 367KB
- caba-ex99_1s17.jpg (GRAPHIC) — 461KB
- caba-ex99_1s18.jpg (GRAPHIC) — 386KB
- caba-ex99_1s19.jpg (GRAPHIC) — 464KB
- caba-ex99_1s20.jpg (GRAPHIC) — 502KB
- caba-ex99_1s21.jpg (GRAPHIC) — 137KB
- caba-ex99_1s22.jpg (GRAPHIC) — 517KB
- caba-ex99_1s23.jpg (GRAPHIC) — 399KB
- caba-ex99_1s24.jpg (GRAPHIC) — 364KB
- caba-ex99_1s25.jpg (GRAPHIC) — 504KB
- caba-ex99_1s26.jpg (GRAPHIC) — 463KB
- caba-ex99_1s27.jpg (GRAPHIC) — 438KB
- caba-ex99_1s28.jpg (GRAPHIC) — 145KB
- caba-ex99_1s29.jpg (GRAPHIC) — 421KB
- caba-ex99_1s30.jpg (GRAPHIC) — 432KB
- caba-ex99_1s31.jpg (GRAPHIC) — 388KB
- caba-ex99_1s32.jpg (GRAPHIC) — 314KB
- caba-ex99_1s33.jpg (GRAPHIC) — 511KB
- caba-ex99_1s34.jpg (GRAPHIC) — 392KB
- caba-ex99_1s35.jpg (GRAPHIC) — 136KB
- caba-ex99_1s36.jpg (GRAPHIC) — 444KB
- caba-ex99_1s37.jpg (GRAPHIC) — 362KB
- caba-ex99_1s38.jpg (GRAPHIC) — 313KB
- caba-ex99_1s39.jpg (GRAPHIC) — 364KB
- caba-ex99_1s40.jpg (GRAPHIC) — 146KB
- caba-ex99_1s41.jpg (GRAPHIC) — 449KB
- caba-ex99_1s42.jpg (GRAPHIC) — 386KB
- caba-ex99_1s43.jpg (GRAPHIC) — 365KB
- caba-ex99_1s44.jpg (GRAPHIC) — 362KB
- caba-ex99_1s45.jpg (GRAPHIC) — 438KB
- caba-ex99_1s46.jpg (GRAPHIC) — 132KB
- caba-ex99_1s47.jpg (GRAPHIC) — 325KB
- caba-ex99_1s48.jpg (GRAPHIC) — 126KB
- caba-ex99_1s49.jpg (GRAPHIC) — 416KB
- caba-ex99_1s50.jpg (GRAPHIC) — 120KB
- caba-ex99_1s51.jpg (GRAPHIC) — 356KB
- caba-ex99_1s52.jpg (GRAPHIC) — 189KB
- 0001193125-25-254610.txt ( ) — 26960KB
- caba-20251029.xsd (EX-101.SCH) — 25KB
- caba-20251029_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On October 29, 2025, Cabaletta Bio, Inc. (the "Company") posted to the "Investors & Media" section of the Company's website at www.cabalettabio.com an updated corporate presentation (the "Corporate Presentation"). A copy of the Corporate Presentation is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01 of this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Cabaletta Bio, Inc. Corporate Presentation, dated October 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CABALETTA BIO, INC. Date: October 29, 2025 By: /s/ Steven Nichtberger Steven Nichtberger Chief Executive Officer and President (Principal Executive Officer)